SIRT1 activating compounds (STACs) negatively regulate pancreatic cancer cell growth and viability through a SIRT1-lysosomal-dependent pathway

Por Chini, Claudia C.S., Netto, Jair M. E., Mondal, Gourish, Guerrico, Anatilde M Gonzalez, Nin, Veronica, Escande, Carlos, Sola-Penna, Mauro, Zhang, Jin-San, Billadeau, Daniel D., Chini, Eduardo N.
Publicado no Clin Cancer Res (2015)